Columnist Caroline Gainer experiences relentless fatigue, chills, and sweating, possibly from COPD and/or chronic ...

Note: This column describes the author’s own experiences with guaifenesin. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. We always ...

While watching coverage of a landslide on my news feed, I was reminded of a time when I had a close brush with one. A carpool I was in just missed it, but the carpool of friends behind us wasn’t so ...

Genentech has announced mixed top-line results from two global clinical trials testing its treatment candidate astegolimab in people with moderate to very severe chronic obstructive pulmonary disease ...

Maybe it’s just me, but it seems that coordinating my healthcare is getting harder. It’s important for those of us with chronic obstructive pulmonary disease (COPD) to coordinate medications and other ...

Now that I have treatment for my depression and inability to sleep, I look a little differently than I used to at the occasions when I feel fatigued. I think it’s important for those of us with ...

Digital inhalers that measure and record inhalation data and that can remotely monitor patients may help predict impending chronic obstructive pulmonary disease (COPD) exacerbations, that is, episodes ...

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with chronic obstructive pulmonary disease (COPD). The treatment, ...

Using e-cigarettes, often called vaping, significantly increases the risk of chronic obstructive pulmonary disease (COPD), a U.S. study suggests. People who used e-cigarettes, which are ...

I remember how hard it was to keep cars, or any other outdoor metal object, clean and looking good when I lived in the steel town of Weirton, West Virginia. That ongoing struggle reminds me of my ...

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with poorly controlled chronic obstructive pulmonary disease (COPD) and high ...